Changes in RANKL, OPG, and 25(OH)D Levels in Children with Leukemia from Diagnosis to Remission.

Salvador Atilano-MiguelLourdes Barbosa-CortésRocío Ortiz-MuñizJorge Maldonado-HernándezJorge A Martin-TrejoMaricela Rodríguez-CruzLourdes Balcázar-HernándezKarina A Solís-LabastidaBenito A Bautista-MartínezAzalia Juárez-MoyaZayra Hernández-PiñónRaeline A Galindo-RodríguezAdriana Chávez-AnayaRosa E Valdez-AvilezJuan M Domínguez-SalgadoJudith Villa-MoralesMaría E Rodríguez-Palacios

Published in: Cancers (2024)

we suggest that the RANKL/OPG ratio could serve as a bone remodeling marker in ALL patients.

Keyphrases

end stage renal disease
bone loss
newly diagnosed
chronic kidney disease
young adults
acute myeloid leukemia
peritoneal dialysis
prognostic factors
nuclear factor
bone marrow
patient reported outcomes
immune response
inflammatory response
toll like receptor